I trained in Melbourne, followed by four years in the United States at the University of Michigan. Over that period of time, I worked in the fields of hypertension and hyperlipidaemia, before returning to Australia where I am a consultant cardiologist at University Hospital Geelong. I hold appointments with Deakin University in the School of Medicine as well as the Department of Epidemiology and Preventative Medicine at Monash University. I am the Director of the Geelong Cardiology Research Unit, which is currently involved in many phase II – III clinical trials. While still involved in hypertension I have also become involved in research in atherothrombosis, especially with respect to antithrombotic/antiplatelet therapies, particularly in the context of atrial fibrillation. Heart failure is a major interest, and I currently sit as the Director of the Heart Failure Programme at University Hospital Geelong.
Research Focus: Heart Failure, Hypertension, Hyperlipidaemia, and Atherothrombosis, Especially with Respect to Antithrombotic/Antiplatelet Therapies, Particularly in the Context of Atrial Fibrillation.
Awards & Achievements: - Australian National Co-ordinator for global clinical trials in cardiovascular disease in several studies - Hold positions on International Steering Committees/Endpoint committees overseeing the conduct of various clinical trials. - Frequently present data from clinical trials outcomes at international Cardiology meetings. Syneos Health Site Award 2018